Glucose biosensors are the devices used for measuring the concentration of glucose in blood of diabetic patient with the help of sensitive protein. Glucose biosensors market is growing at faster pace majorly due to high prevalence of diabetes coupled with increasing ageing population. According to the World Health Organization, in 2013 there were 347 million people suffering from diabetes and number is expected to increase to 552 million by 2030. Abbott point-of-care, Inc. has launched portable biosensor with the name i-STAT system which enables health care professional to access real time, lab-quality results within minutes and the system is designed such that it could benefit almost all the departments of the hospitals including surgical services, neonatal ICU, cardiology lab, radiology and respiratory therapy.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/glucose-biosensors-market.html